We strive to achieve the highest internal standards
of excellence, from our rigorous scientific approach,
through to product development and distribution.

We select our partners, shareholders and suppliers
with these high benchmarks of excellence in mind.


We are committed to fostering a culture of scientific innovation
to deliver new, more accurate and cost-effective diagnostic
technologies and products.

Innovation is at the core of our business to
drive transformation in the diagnostic sector.


We are committed to improving the lives
of cancer patients and their families and
we hold our business partners to the same
high standards we ourselves aspire to.